Mechanisms of Protection of Hematopoietic Stem Cells from Irradiation

References

• Walker R.I. Acute radiation injuries. Pharmacol. Therapeutics 1988; 39: 9–12
   PubMed Web of Science ®Google Scholar
• Murray D., Prager A., Meyn R.E., Milas L. Radioprotective agents as modulators of cell and tissue radio-sensitivity. Cancer Bull 1992; 44: 137–144
   Google Scholar
• Goffman T.E., Raubitschek A., Mitchell J.B., Glar-Stein E. The emerging biology of modern radiation oncology. Cancer Res. 1990; 50: 7735–7744
   PubMed Web of Science ®Google Scholar
• Kumar K.S., Vaishnav Y.N., Weiss J.F. Ra-dioprotection by antioxidant enzymes and enzyme mimetics. Pharmacol. Therapeutics 1988; 39: 301–309
   PubMed Web of Science ®Google Scholar
• Patt H.M., Tyres E.B., Straube R.L. Cysteine protection against X-irradiation. Science 1949; 110: 213–214
   PubMed Web of Science ®Google Scholar
• Coleman C.N., Bump E.A., Kramer R.A. Chemical modifiers of cancer treatment. J. Clin. Oncol. 1988; 6: 709–733
   PubMed Web of Science ®Google Scholar
• Yuhas J. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid. Cancer Res. 1980; 40: 1519–1524
   PubMed Web of Science ®Google Scholar
• Glover D., Glick J., Weiler C. Phase I trials of WR-2721 and cis-platinum. Int. J. Radiat. Oncol. Biol. Phys. 1984; 10: 1781–1784
   PubMed Web of Science ®Google Scholar
• Yuhas J.M. Biological factors affecting the radioprotective efficiency of S-2-(3-aminopropylamino)ethylphos-phorothioic acid (WR-2721). Radiat. Res. 1970; 44: 632–638
   Google Scholar
• Walden T.L. A paradoxical role for eicosaniods: Ra-dioprotectants and radiosensitizers. Prostaglandin and Lipid Metabolism in Radiation Injury, T.L. Walden, H.M. Hughes. Plenum, New York 1987; 263–271
   Google Scholar
• Walden T.L. Leukotriene C4-induced radioprotec-tion: The role of hypoxia. Radiat. Res. 1992; 132: 359–367
   PubMed Web of Science ®Google Scholar
• Walden T.L., Patchen M.L., MacVittie T.J. Leukotriene-induced radioprotection of hematopoietic stem cells in mice. Radiat. Res. 1988; 113: 388–395
   PubMed Web of Science ®Google Scholar
• Hansen W.R. Radiation protection by exogenous ar-achidonic acid and several metabolites. Prostaglandin and Lipid Metabolism in Radiation Injury, T.L. Walden, H.M. Hughes. Plenum, New York 1987; 233–243
   Google Scholar
• Walden T.L. Pretreatment with leukotriene C4 enhances the whole-animal survival of mice exposed to ionizing radiation. Ann. NY Acad. Sci. 1988; 524: 431–433
   Web of Science ®Google Scholar
• Yuhas J.M., Storer J. Chemoprotection against three modes of radiation death in the mouse. Int. J. Radiat. Biol. 1969; 15: 233–237
   Web of Science ®Google Scholar
• Ramakrishnan N., Wolfe W.W., Catravas G.N. Radioprotection of hematopoietic tissues in mice by lipoic acid. Radiat. Res. 1992; 130: 360–365
   PubMed Web of Science ®Google Scholar
• Floersheim G.L. Calcium antagonists protect mice against lethal doses of ionizing radiation. Br. J. Radiol. 1992; 65: 1025–1029
   PubMed Web of Science ®Google Scholar
• Floersheim G.L. radioprotective effects of calcium antagonists used alone or with other types of radioprotectors. Radiat. Res. 1993; 133: 80–87
   PubMed Web of Science ®Google Scholar
• Smith W.W., Alderman I.M., Gillespie R.E. Increased survival in irradiated animals treated with bacterial endotoxins. Am. J. Physiol. 1957; 192: 549–556
   Google Scholar
• Ainsworth E.I., Chase H.B. Effect of microbial antigens on irradiation mortality in mice. Porc. Soc. Exp. Biol. Med. 1959; 102: 483–485
   PubMed Web of Science ®Google Scholar
• Ainsworth E.J., Hatch M.H. The effect of Pro teusmorgani endotoxin on radiation mortality in mice. Radiat. Res. 1960; 13: 767–774
   Web of Science ®Google Scholar
• Neta R., Douches S., Oppenheim J.J. Interleu-kin-1 is a radioprotector. J. Immunol. 1986; 136: 2483–2485
   PubMed Web of Science ®Google Scholar
• Neta R., Oppenheim J.J., Douches S.D. Inter dependence of the radioprotective effects of human recombinant IL-1, TNF-α, G-CSF, and murine recombinant G-CSF. J. Immunol. 1988; 140: 108–111
   PubMed Web of Science ®Google Scholar
• Neta R., Oppenheim J.J. Cytokines in therapy of radiation injury. Blood 1988; 72: 1093–1095
   PubMed Web of Science ®Google Scholar
• Slordal L., Muench M.O., Warren D.J., Moore M. A. S. Radioprotection by murine and human tumor necrosis factor: Dose-dependent effects on hematopoiesis in the mouse. Eur. J. Haematol. 1989; 43: 428–434
   PubMed Web of Science ®Google Scholar
• Slordal L., Warren D.J., Moore M. A. S. Effects of recombinant murine tumor necrosis factor on hematopoietic reconstitution in sublethally irradiated mice. J. Immunol. 1989; 142: 833–835
   PubMed Web of Science ®Google Scholar
• Neta R., Oppenheim J.J., Schreiber R.D., Chizzonite R., Ledney G.D., MacVittie T.J. Role of cytokines (interleukin 1, tumor necrosis factor and transforming growth factor β) in natural and lipopolysaccharide-induced radioresistance. J. Exp. Med. 1991; 173: 177–182
   Web of Science ®Google Scholar
• Oppenheim J.J., Neta R., Tiberghian R., Cress R., Kenny J.J., Longo D.L. Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone mar row cells. Blood 1989; 74: 2257–2263
   PubMed Web of Science ®Google Scholar
• Schwartz G.N., Neta R., Vigneulle R.M., Patchen M.L., MacVittie T.J. recovery of hematopoietic colony-forming cells in irradiated mice pretreated with interleu kin-1 (IL-1). Exp. Hematol. 1988; 16: 752–757
   PubMed Web of Science ®Google Scholar
• Neta R., Sztein M.B., Oppenheim J.J., Gillis S., Douches S.D. The in vivo effects of interleukin I. 1. Bone marrow cells are induced to cycle after administration of interleukin 1. J. Immunol. 1987; 139: 1861–1866
   PubMed Web of Science ®Google Scholar
• Zsebo K.M., Smith K.A., Hartley C.A., Greenblatt M., Cooke K., Rich W., McNiece I.K. Radiopro tection of mice by recombinant rat stem cell factor. Proc. Natl. Acad. Sci. USA 1992; 89: 9464–9468
   PubMed Web of Science ®Google Scholar
• Neta R., Williams D., Selzer F., Abrams J. Inhibition of c-kit ligand/steel factor by antibodies reduces survival of lethally irradiated mice. Blood 1993; 81: 324–327
   PubMed Web of Science ®Google Scholar
• Neta R., Erlstein R., Vogel S.F., Ledney G.D., Abrams J. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. J. Exp. Med. 1992; 175: 689–694
   PubMed Web of Science ®Google Scholar
• Eastgate J., Moreb J., Nick H.S., Suzuki K., Taniguchi N., Zucali J.R. A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-I. Blood 1993; 81: 639–647
   PubMed Web of Science ®Google Scholar
• Zucali J.R., Moreb J., Gibbons W., Alderman J., Suresh A., Zhang Y., Shelby B. Radioprotection of he matopoietic stem cells by interleukin-l. Exp. Hematol. 1993, Submitted to
   PubMedGoogle Scholar
• Lajtha L.G., Pozzi L.V., Schofield R., Fox M. Kinetic properties of haemopoietic stem cells. Cell Tissue Ki-net. 1969; 2: 39–49
   Google Scholar
• Wong G. H. W., Goeddel D.V. Induction of manganese superoxide dismutase by tumor necrosis factor: Possible protective mechanisms. Science 1988; 242: 941–944
   PubMed Web of Science ®Google Scholar
• Visner G.A., Dougall W.C., Wilson J.M., Burr I.A., Nick H.S. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-I and tumor necrosis factor. J. Biol. Chem. 1990; 265: 2856–2864
   PubMed Web of Science ®Google Scholar
• Masuda A., Longo D.L., Kobayashi Y., Appela E., Op penheim J.J., Matsushima K. Induction of mi-tochondrial manganese superoxide dismutase by interleukin-I. FASEB J. 1988; 2: 3087–3091
   PubMed Web of Science ®Google Scholar
• Tsuji Y., Watanabe N., Okamoto T., Tsuji N., Sasaki H., Okizawa S., Yamauchi N., Niitsu Y. En dogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res. 1992; 52: 6258–6262
   PubMed Web of Science ®Google Scholar
• Wong G. H. W., Elwell J.H., Oberley L.W., Goed-Del D.V. Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923–932
   PubMed Web of Science ®Google Scholar
• Wong G. H. W., McHugh T., Weber R., Goeddel D.V. Tumor necrosis factor α selectively sensitizes human immunodeficiency virus-infected cells to heat and radiation. Proc. Natl. Acad. Sci. USA 1991; 88: 4372–4376
   PubMed Web of Science ®Google Scholar
• St. Clair D.K., Oberley T.D., Ho Y.-S. Over production of human Mn-superoxide dismutase modulates paraquat-mediated toxicity in mammalian cells. Fed. Eur. Biochem. Soc. 1991; 293: 199–203
   PubMed Web of Science ®Google Scholar
• Petkau A., Kelly K., Chelack W.S., Pleskoch S.D., Barefoot C., Meeker B.E. Radioprotection of bone marrow stem cells by superoxide dismutase. Biochem. Biophys. Res. Commun. 1975; 67: 1167–1174
   PubMed Web of Science ®Google Scholar
• Petkau A., Chelack W.S. Radioprotection by superoxide dismutase of macrophage progenitor cells from mouse bone marrow. Biochem. Biophys. Res. Commun. 1984; 119: 1089–1095
   PubMed Web of Science ®Google Scholar
• Machlin L.J., Bendich A. Free radical tissue damage: Protective role of antioxidant nutrients. FASEB J. 1987; 1: 441–445
   PubMed Web of Science ®Google Scholar
• Touati D. Molecular genetics of superoxide dismu-tases. Free Rad. Biol. Med. 1988; 5: 393–402
   PubMed Web of Science ®Google Scholar
• Thornulley P.J., Vasak M. Possible role for me-tallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochem. Biophs. Acta 1985; 827: 36–74
   PubMed Web of Science ®Google Scholar
• Karin M., Inbra R.J., Heguy J., Wong G. In-terleukin I regulates human metallothionein gene expression. Mole. Cell Biol. 1985; 5: 2866–2869
   PubMed Web of Science ®Google Scholar
• Matubara J., Tajima Y., Karasawa M. Promotion of radioresistance by metallothionein induction prior to irradiation. Environ. Res. 1987; 43: 66–74
   PubMed Web of Science ®Google Scholar
• Mitchell J.B., Biaglow J.E., Russo A. Role of glutathione and other endogenous thiols in radiation pro tection. Pharmacol. Therapeutics 1988; 39: 269–274
   PubMed Web of Science ®Google Scholar
• Hirose K., Longo D.L., Oppenheim J.J., Matsushima K. Overexpression of mitochondrial manganese su peroxide dismutase promotes the survival of tumor cells ex posed to interleukin-I, tumor necrosis factor, selected anti-cancer drugs and ionizing radiation. FASEB J. 1993; 7: 361–368
   PubMed Web of Science ®Google Scholar
• Suresh A., Zucali J.R., Tung F. Role of man ganese superoxide dismutase in radioprotection. Exptl. He-matol. 1993; 21: 1028
   Web of Science ®Google Scholar